ProKidney Corp (NASDAQ:PROK) currently has a daily average trading volume of 757.92K but it saw 1087412 shares traded in last market. With a market cap of 259.21M USD, the company’s current market price of $0.89 came falling about -18.00 while comparing to the previous closing price of $1.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.44 and as low as $0.46. In the recent trading on the day, stock has struck highest price mark of $0.8802 while lowest mark touched by it was $1.07.
Taking a look at 20-day trading activity of ProKidney Corp (PROK) gives us an average price of $0.7808, while its current price level is -80.05% below from 52-week high level whereas it is 92.40% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.9718 while that of 200 days or SMA-200 reads an average of $1.6952. A closer look into the stock’s movement over the week reveals that its volatility is standing at 16.22% during that period while stretching the period over a month that increases to 23.47%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.80 which implies that the stock is in neutral territory.
Morgan Stanley issued its recommendations for the stock as it resumed the price target for the stock is $3.
Over the week, PROK’s stock price is moving -2.69% down while it is 1.07% when we observe its performance for the past one month. Year-to-date it is -47.60% down and over the past year, the stock is showing a downside performance of -58.23%.
The company is expected to be releasing its next quarterly report on 2025-Mar-16, for which analysts forecasted an EPS of -0.15 while estimate for next year EPS is -0.6.
Currently, ProKidney Corp’s total number of outstanding shares is 128.05M with 30.05% of that held by the insiders while 44.35% of its common stock has been owned by the institutions. Stock’s beta reads 1.55. Stock has a price to sale or P/S ratio amounts to 3240.12. Its return on asset (ROA) is -14.18% on average.
